Table of contents

Ovarian Cancer

• Survival After Primary Debulking Surgery Compared With Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A National Cancer Database Study (1 October, 2017)

  Brandon-Luke L. Seagle, Stephen Graves, Anna E. Strohl, Shohreh Shahabi
• Resisting RECIST—Uniformity Versus Clinical Validity (1 October, 2017)

  Michelle K. Wilson, Michael L. Friedlander, Stephanie Lheureux, William Small, Andrés Poveda, Eric Pujade-Lauraine, Katherine Karakasis, Monica Bacon, Valerie Bowering, Tanya Chawla, Amit M. Oza
• Time Trends in the Incidence and Mortality of Ovarian Cancer in Ireland, Northern Ireland, and Israel, 1994–2013 (1 October, 2017)

  Lital Keinan-Boker, Barbara G. Silverman, Paul M. Walsh, Anna T. Gavin, Catherine Hayes
• Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer: Manitoba Ovarian Cancer Outcomes (MOCO) Study Group (1 October, 2017)

  Alon D. Altman, Pascal Lambert, Allison J. Love, Donna Turner, Robert Lotocki, Erin Dean, Shaundra Popowich, Mark W. Nachtigal
• Barriers to Primary Debulking Surgery for Advanced Ovarian Cancer in Latin America (1 October, 2017)

  Eduardo Paulino, Angelica Nogueira Rodrigues, Kathrin Strasser-Weippl, Jessica St. Louis, Alexandra Bukowski, Paul E. Goss
• The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients

  (1 October, 2017)

  Xiaohua Wu, Lingying Wu, Beihua Kong, Jihong Liu, Rutie Yin, Hao Wen, Ning Li, Hualei Bu, Yanling Feng, Qingli Li, Xuesong Lu, Jia Wei, Xuehua Zhu, John Mills, Gillian Ellison, Thorsten Gutjahr, Yuzhen Liu
• Genetic Versus Epigenetic BRCA1 Silencing Pathways: Clinical Effects in Primary Ovarian Cancer Patients

  (1 October, 2017)

  Tingting Sun, Ilary Ruscito, Desislava Dimitrova, Radoslav Chekerov, Hagen Kulbe, Udo Baron, Véronique Blanchard, Pierluigi Benedetti Panici, Silvia Darb-Esfahani, Jalid Sehouli, Sven Olek, Elena Ioana Braicu
• Inhibition of Aurora Kinase A Synergistically Enhances Cytotoxicity in Ovarian Clear Cell Carcinoma Cell Lines Induced by Cisplatin: A Potential Treatment Strategy (1 October, 2017)

  Yohei Chiba, Seiya Sato, Hiroaki Itamochi, Naoto Yoshino, Daisuke Fukagawa, Hideki Kawamura, Yasuko Suga, Atsumi Kojima-Chiba, Yasushi Muraki, Tamotsu Sugai, Toru Sugiyama